The particle detector in your pocket: The Distributed Electronic Cosmic-ray Observatory

The total area of silicon in cell phone camera sensors worldwide surpasses that in any experiment to date. Based on semiconductor technology similar to that found in modern astronomical telescopes and particle detectors, these sensors can detect ionizing radiation in addition to photons. The Distributed Electronic Cosmic-ray Observatory (DECO) uses the global network of active cell phones in order to detect cosmic rays and other energetic particles such as those produced by radioactive decays. DECO consists of an Android application, database, and public data browser available to citizen scientists around the world (https://wipac.wisc.edu/deco). Candidate cosmic-ray events have been detected on all seven continents and can be categorized by the morphology of their corresponding images. We present the DECO project, a novel particle detector with wide applications in public outreach and education.Comment: Presented at ICRC 2017, Busan, Korea. See https://wipac.wisc.edu/deco for more informatio

Ecología y diagnóstico de Enallodiplosis discordis (Diptera:Cecidomyiidae): Un nuevo defoliador feroz con repercusiones directas en la pérdida del bosque seco de Prosopis y los medios de vida en Perú

The coastal desert of Peru and Chile is home to Prosopis (Leguminosae: Mimosoideae) tree species that are exceptionally well-adapted to the hyperarid conditions and keystone in dry-forest ecosystems. From 2001 to 2018, Prosopis in Peru have suffered widespread defoliation and die-back, with consequent deforestation and collapse in pod production. This paper reports a new insect plague species of Prosopis forest in Peru: Enallodiplosis discordis Gagné 1994 (Diptera: Cecidomyiidae) as a fiercely defoliating agent contributing to widespread Prosopis mortality. An analysis of E. discordis larval taxonomy, life cycle and plague infestation, following El Niño Southern Oscillation (ENSO) 1998/99 is provided. Using distinct lines of evidence, its spread, distribution, and ecology are examined. Over two decades of fieldwork, Prosopis forest die-back and loss was observed devastating rural livelihoods and ecosystem services across lowland regions of southern (Ica), central and northern coastal Peru (Lambayeque, La Libertad, Piura). The collapse in production of Prosopis pods (algarroba, huaranga) and honey was recorded. Supplementary notes provide observations of: (i) plague development, changing land-use and climate, (ii) biological and physical control of E. discordis, (iii) the moth Melipotis aff. indomita (Lepidoptera: Noctuidae) as a concurrent defoliator of Prosopis.Las regiones desérticas costeras del Pacífico de Perú y Chile albergan especies de Prosopis (Leguminosae: Mimosoideae), árboles bien adaptados a las condiciones del desierto y con funciones clave en los ecosistemas de bosques secos. Entre el 2001 y 2017, Prosopis en Perú ha sufrido una extensiva defoliación y muerte regresiva, con la consecuente deforestación y disminución de la producción de vainas de algarrobo. Aquí, se reporta una nueva especie de insecto plaga del bosque de Prosopis en Perú: Enallodiplosis discordis Gagné 1994 (Diptera: Cecidomyiidae), una feroz especie defoliadora que contribuye a la mortalidad generalizada de Prosopis. Se proporciona un análisis de la taxonomía larvaria de E. discordis, ciclo de vida y la infestación ocurrida después de El Niño Oscilación del Sur (ENSO) 1998/99. Su dispersión, distribución y ecología es examinada utilizando distintas líneas de evidencia. Durante casi dos décadas de trabajo de campo, se observó la muerte regresiva del bosque de Prosopis devastando los medios de vida rurales y los servicios de los ecosistemas en las regiones de las tierras bajas del sur (Ica), el centro y el norte de la costa peruana (Lambayeque, La Libertad, Piura). El colapso en la producción de vainas de Prosopis (algarroba, huaranga) y miel también fue registrada. Las notas complementarias proporcionan observaciones sobre: (i) el desarrollo de la plaga y el cambio de uso de la tierra y el clima, (ii) el control biológico y físico de E. discordis, (iii) la polilla Melipotis aff. indomita (Lepidoptera: Noctuidae) como defoliador concurrente de Prosopis

Antimicrobial resistance among migrants in Europe: a systematic review and meta-analysis

BACKGROUND: Rates of antimicrobial resistance (AMR) are rising globally and there is concern that increased migration is contributing to the burden of antibiotic resistance in Europe. However, the effect of migration on the burden of AMR in Europe has not yet been comprehensively examined. Therefore, we did a systematic review and meta-analysis to identify and synthesise data for AMR carriage or infection in migrants to Europe to examine differences in patterns of AMR across migrant groups and in different settings. METHODS: For this systematic review and meta-analysis, we searched MEDLINE, Embase, PubMed, and Scopus with no language restrictions from Jan 1, 2000, to Jan 18, 2017, for primary data from observational studies reporting antibacterial resistance in common bacterial pathogens among migrants to 21 European Union-15 and European Economic Area countries. To be eligible for inclusion, studies had to report data on carriage or infection with laboratory-confirmed antibiotic-resistant organisms in migrant populations. We extracted data from eligible studies and assessed quality using piloted, standardised forms. We did not examine drug resistance in tuberculosis and excluded articles solely reporting on this parameter. We also excluded articles in which migrant status was determined by ethnicity, country of birth of participants' parents, or was not defined, and articles in which data were not disaggregated by migrant status. Outcomes were carriage of or infection with antibiotic-resistant organisms. We used random-effects models to calculate the pooled prevalence of each outcome. The study protocol is registered with PROSPERO, number CRD42016043681. FINDINGS: We identified 2274 articles, of which 23 observational studies reporting on antibiotic resistance in 2319 migrants were included. The pooled prevalence of any AMR carriage or AMR infection in migrants was 25·4% (95% CI 19·1-31·8; I2 =98%), including meticillin-resistant Staphylococcus aureus (7·8%, 4·8-10·7; I2 =92%) and antibiotic-resistant Gram-negative bacteria (27·2%, 17·6-36·8; I2 =94%). The pooled prevalence of any AMR carriage or infection was higher in refugees and asylum seekers (33·0%, 18·3-47·6; I2 =98%) than in other migrant groups (6·6%, 1·8-11·3; I2 =92%). The pooled prevalence of antibiotic-resistant organisms was slightly higher in high-migrant community settings (33·1%, 11·1-55·1; I2 =96%) than in migrants in hospitals (24·3%, 16·1-32·6; I2 =98%). We did not find evidence of high rates of transmission of AMR from migrant to host populations. INTERPRETATION: Migrants are exposed to conditions favouring the emergence of drug resistance during transit and in host countries in Europe. Increased antibiotic resistance among refugees and asylum seekers and in high-migrant community settings (such as refugee camps and detention facilities) highlights the need for improved living conditions, access to health care, and initiatives to facilitate detection of and appropriate high-quality treatment for antibiotic-resistant infections during transit and in host countries. Protocols for the prevention and control of infection and for antibiotic surveillance need to be integrated in all aspects of health care, which should be accessible for all migrant groups, and should target determinants of AMR before, during, and after migration. FUNDING: UK National Institute for Health Research Imperial Biomedical Research Centre, Imperial College Healthcare Charity, the Wellcome Trust, and UK National Institute for Health Research Health Protection Research Unit in Healthcare-associated Infections and Antimictobial Resistance at Imperial College London

Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy

Myelodysplastic syndromes (MDS) are heterogeneous neoplastic disorders of hematopoietic stem cells (HSCs). The current standard of care for patients with MDS is hypomethylating agent (HMA)-based therapy; however, almost 50% of MDS patients fail HMA therapy and progress to acute myeloid leukemia, facing a dismal prognosis due to lack of approved second-line treatment options. As cancer stem cells are the seeds of disease progression, we investigated the biological properties of the MDS HSCs that drive disease evolution, seeking to uncover vulnerabilities that could be therapeutically exploited. Through integrative molecular profiling of HSCs and progenitor cells in large patient cohorts, we found that MDS HSCs in two distinct differentiation states are maintained throughout the clinical course of the disease, and expand at progression, depending on recurrent activation of the anti-apoptotic regulator BCL-2 or nuclear factor-kappa B-mediated survival pathways. Pharmacologically inhibiting these pathways depleted MDS HSCs and reduced tumor burden in experimental systems. Further, patients with MDS who progressed after failure to frontline HMA therapy and whose HSCs upregulated BCL-2 achieved improved clinical responses to venetoclax-based therapy in the clinical setting. Overall, our study uncovers that HSC architectures in MDS are potential predictive biomarkers to guide second-line treatments after HMA failure. These findings warrant further investigation of HSC-specific survival pathways to identify new therapeutic targets of clinical potential in MDS

Biological Treatment and the Potential Risk of Adverse Postoperative Outcome in Patients With Inflammatory Bowel Disease: An Open-Source Expert Panel Review of the Current Literature and Future Perspectives

Abstract Background There is widespread concern that treatment with biologic agents may be associated with suboptimal postoperative outcome after surgery for inflammatory bowel diseases (IBD). Aim We aimed to search and analyze the literature regarding the potential association of biologic treatment on adverse postoperative outcome in patients with IBD. We used the subject as a case in point for surgical research. The aim was not to conduct a new systematic review. Method This is an updated narrative review written in a collaborative method by authors invited through Twitter via the following hashtags (#OpenSourceResearch and #SoMe4Surgery). The manuscript was presented as slides on Twitter to allow discussion of each section of the paper sequentially. A Google document was created, which was shared across social media, and comments and edits were verified by the primary author to ensure accuracy and consistency. Results Forty-one collaborators responded to the invitation, and a total of 106 studies were identified that investigated the potential association of preoperative biological treatment on postoperative outcome in patients with IBD. Most of these studies were retrospective observational cohorts: 3 were prospective, 4 experimental, and 3 population-based studies. These studies were previously analyzed in 10 systematic/narrative reviews and 14 meta-analyses. Type of biologic agents, dose, drug concentration, antidrug antibodies, interval between last dose, and types of surgery varied widely among the studies. Adjustment for confounders and bias control ranged from good to very poor. Only 10 studies reported postoperative outcome according to Clavien–Dindo classification. Conclusion Although a large number of studies investigated the potential effect of biological treatment on postoperative outcomes, many reported divergent results. There is a need for randomized controlled trials. Future studies should focus on the avoiding the weakness of prior studies we identified. Seeking collaborators and sharing information via Twitter was integral to widening the contributors/authors and peer review for this article and was an effective method of collaboration

DU Undergraduate Showcase: Research, Scholarship, and Creative Works: Abstracts

Abstracts from the DU Undergraduate Showcase

DU Undergraduate Showcase: Research, Scholarship, and Creative Works

DU Undergraduate Showcase: Research, Scholarship, and Creative Work